A Systematic Review and Meta-Analysis of the Effectiveness of Adherence Therapy and Its Treatment Duration in Patients with Schizophrenia Spectrum Disorders

References

• Kishi T, Ikuta T, Matsui Y, et al. Effect of discontinuation v. maintenance of antipsychotic medication on relapse rates in patients with remitted/stable first-episode psychosis: a meta-analysis. Psychol Med. 2019;49(5):772–779. doi:10.1017/S0033291718001393
   PubMed Web of Science ®Google Scholar
• Zipursky RB, Menezes NM, Streiner DL. Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review. Schizophr Res. 2014;152(2–3):408–414. doi:10.1016/j.schres.2013.08.001
   PubMed Web of Science ®Google Scholar
• Lauriello J. Prevalence and impact of relapse in patients with schizophrenia. J Clin Psychiatry. 2020;81(2):2. doi:10.4088/JCP.MS19053BR1C
   Web of Science ®Google Scholar
• Tham XC, Xie H, Chng CM, Seah XY, Lopez V, Klainin-Yobas P. Factors affecting medication adherence among adults with schizophrenia: a literature review. Arch Psychiatr Nurs. 2016;30(6):797–809. doi:10.1016/j.apnu.2016.07.007
   PubMed Web of Science ®Google Scholar
• Abdel-Baki A, Ouellet-Plamondon C, Malla A. Pharmacotherapy challenges in patients with first-episode psychosis. J Affect Disord. 2012;138(Suppl):S3–14. doi:10.1016/j.jad.2012.02.029
   PubMedGoogle Scholar
• Haddad PM, Brain C, Scott J. Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies. Patient Relat Outcome Meas. 2014;5:43–62. doi:10.2147/PROM.S42735
   PubMedGoogle Scholar
• Häge A, Weymann L, Bliznak L, Märker V, Mechler K, Dittmann RW. Non-adherence to psychotropic medication among adolescents - A systematic review of the literature. Z Kinder Jugendpsychiatr Psychother. 2018;46(1):69–78. doi:10.1024/1422-4917/a000505
   PubMed Web of Science ®Google Scholar
• Novick D, Haro JM, Suarez D, Perez V, Dittmann RW, Haddad PM. Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Psychiatry Res. 2010;176(2–3):109–113. doi:10.1016/j.psychres.2009.05.004
   PubMed Web of Science ®Google Scholar
• Semahegn A, Torpey K, Manu A, Assefa N, Tesfaye G, Ankomah A. Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis. Syst Rev. 2020;9(1):17. doi:10.1186/s13643-020-1274-3
   PubMed Web of Science ®Google Scholar
• Bartoli F, Cavaleri D, Callovini T, et al. Comparing 1-year effectiveness and acceptability of once-monthly paliperidone palmitate and aripiprazole monohydrate for schizophrenia spectrum disorders: findings from the STAR network depot study. Psychiatry Res. 2022;309:114405. doi:10.1016/j.psychres.2022.114405
   PubMed Web of Science ®Google Scholar
• Chan SW, Li Z, Klainin-Yobas P, Ting S, Chan MF, Eu PF. Effectiveness of a peer-led self-management programme for people with schizophrenia: protocol for a randomized controlled trial. J Adv Nurs. 2014;70(6):1425–1435. doi:10.1111/jan.12306
   PubMed Web of Science ®Google Scholar
• Olivares JM, Sermon J, Hemels M, Schreiner A. Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review. Ann Gen Psychiatry. 2013;12(1):32. doi:10.1186/1744-859X-12-32
   PubMed Web of Science ®Google Scholar
• Gray R, Wykes T, Gournay K. From compliance to concordance: a review of the literature on interventions to enhance compliance with antipsychotic medication. J Psychiatr Ment Health Nurs. 2002;9(3):277–284. doi:10.1046/j.1365-2850.2002.00474.x
   PubMedGoogle Scholar
• Velligan DI, Sajatovic M, Hatch A, Kramata P, Docherty JP. Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness. Patient Prefer Adherence. 2017;11:449–468. doi:10.2147/PPA.S124658
   PubMed Web of Science ®Google Scholar
• Wade M, Tai S, Awenat Y, Haddock G. A systematic review of service-user reasons for adherence and nonadherence to neuroleptic medication in psychosis. Clin Psychol Rev. 2017;51:75–95. doi:10.1016/j.cpr.2016.10.009
   PubMed Web of Science ®Google Scholar
• Loots E, Goossens E, Vanwesemael T, Morrens M, Van Rompaey B, Dilles T. Interventions to improve medication adherence in patients with schizophrenia or bipolar disorders: a systematic review and meta-analysis. Int J Environ Res Public Health. 2021;18:19. doi:10.3390/ijerph181910213
   Web of Science ®Google Scholar
• Gray R, Leese M, Bindman J, et al. Adherence therapy for people with schizophrenia. European multicentre randomised controlled trial. Br J Psychiatry. 2006;189:508–514. doi:10.1192/bjp.bp.105.019489
   PubMed Web of Science ®Google Scholar
• Hsieh WL, Lee SK, Chien WT, Liu WI, Lai CY, Liu CY. Mediating effect of the motivation for medication use on disease management and medication adherence among community-dwelling patients with schizophrenia. Patient Prefer Adherence. 2019;13:1877–1887. doi:10.2147/PPA.S218553
   PubMed Web of Science ®Google Scholar
• Wong-Anuchit C, Chantamit OPC, Schneider JK, Mills AC. Motivational interviewing-based compliance/adherence therapy interventions to improve psychiatric symptoms of people with severe mental illness: meta-analysis. J Am Psychiatr Nurses Assoc. 2019;25(2):122–133. doi:10.1177/1078390318761790
   PubMed Web of Science ®Google Scholar
• Gray R, Bressington D, Ivanecka A, et al. Is adherence therapy an effective adjunct treatment for patients with schizophrenia spectrum disorders? A systematic review and meta-analysis. BMC Psychiatry. 2016;16:90. doi:10.1186/s12888-016-0801-1
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman D, Tetzlaff J, et al. The PRISMA statement for systematic review and meta-analysis of studies that evaluate health care intervention: explanation and elaboration. J Clin Epidemiol. 2009;62:10. doi:10.1016/j.jclinepi.2009.06.006
   Google Scholar
• Higgins JP, Altman DG, Gøtzsche PC, et al. The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi:10.1136/bmj.d5928
   PubMed Web of Science ®Google Scholar
• Rosenthal JA. Qualitative descriptors of strength of association and effect size. J Soc Serv Res. 1996;21(4):37–59. doi:10.1300/J079v21n04_02
   Web of Science ®Google Scholar
• Chien WT, Cheung EFC, Mui JHC, Gray R, Ip G. Adherence therapy for schizophrenia: a randomised controlled trial. Hong Kong Med J. 2019;2(1):4–9.
   Google Scholar
• Maneesakorn S, Robson D, Gournay K, Gray R. An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand. J Clin Nurs. 2007;16(7):1302–1312. doi:10.1111/j.1365-2702.2007.01786.x
   PubMed Web of Science ®Google Scholar
• Schulz M, Gray R, Spiekermann A, Abderhalden C, Behrens J, Driessen M. Adherence therapy following an acute episode of schizophrenia: a multi-centre randomised controlled trial. Schizophr Res. 2013;146(1–3):59–63. doi:10.1016/j.schres.2013.01.028
   PubMed Web of Science ®Google Scholar
• von Bormann S, Robson D, Gray R. Adherence therapy following acute exacerbation of schizophrenia: a randomised controlled trial in Thailand. Int J Soc Psychiatry. 2015;61(1):3–9. doi:10.1177/0020764014529099
   PubMed Web of Science ®Google Scholar
• Zomahoun HTV, Guénette L, Grégoire JP, et al. Effectiveness of motivational interviewing interventions on medication adherence in adults with chronic diseases: a systematic review and meta-analysis. Int J Epidemiol. 2017;46(2):589–602. doi:10.1093/ije/dyw273
   PubMed Web of Science ®Google Scholar
• Lam WY, Fresco P. Medication adherence measures: an overview. Biomed Res Int. 2015;2015:1–12. doi:10.1155/2015/217047
   Web of Science ®Google Scholar
• Heslop B, Wynaden D, Tohotoa J, Heslop K. Mental health nurses’ contributions to community mental health care: an Australian study. Int J Ment Health Nurs. 2016;25(5):426–433. doi:10.1111/inm.12225
   PubMed Web of Science ®Google Scholar
• Alyahya NM, Munro I, Moss C. The experience of psychosis and recovery from consumers’ perspectives: an integrative literature review. J Psychiatr Ment Health Nurs. 2022;29(1):99–115. doi:10.1111/jpm.12696
   PubMed Web of Science ®Google Scholar
• Miller WR, Rose GS. Toward a theory of motivational interviewing. Am Psychol. 2009;64(6):527–537. doi:10.1037/a0016830
   PubMed Web of Science ®Google Scholar
• Clifford L, Crabb S, Turnbull D, Hahn L, Galletly C. A qualitative study of medication adherence amongst people with schizophrenia. Arch Psychiatr Nurs. 2020;34(4):194–199. doi:10.1016/j.apnu.2020.06.002
   PubMed Web of Science ®Google Scholar
• Salzmann-Erikson M, Sjödin M. A narrative meta-synthesis of how people with schizophrenia experience facilitators and barriers in using antipsychotic medication: implications for healthcare professionals. Int J Nurs Stud. 2018;85:7–18. doi:10.1016/j.ijnurstu.2018.05.003
   PubMed Web of Science ®Google Scholar
• Leclerc E, Noto C, Bressan RA, Brietzke E. Determinants of adherence to treatment in first-episode psychosis: a comprehensive review. Rev Bras Psiquiatr. 2015;37(2):168–176. doi:10.1590/1516-4446-2014-1539
   PubMed Web of Science ®Google Scholar
• Steinkamp JM, Goldblatt N, Borodovsky JT, et al. Technological interventions for medication adherence in adult mental health and substance use disorders: a systematic review. JMIR Mental Health. 2019;6(3):e12493. doi:10.2196/12493
   PubMed Web of Science ®Google Scholar